Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

René G Feichtinger

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Journal of Oncology|November 30, 2019
Targeting L-Lactate Metabolism to Overcome Resistance to Immune Therapy of Melanoma and Other Tumor EntitiesRené G Feichtinger, Roland Lang
Experimental Dermatology|July 2, 2014
Mitochondrial dysfunction: a neglected component of skin diseasesRené G Feichtinger, Wolfgang Sperl, Johann W Bauer, et al.
Journal of Mother and Child|November 12, 2020
The switch in the diagnosis of mitochondrial diseases from the classical 'function first' to the NGS-based 'genetics first' diagnostic eraWolfgang Sperl, Saskia Wortmann, René G Feichtinger, et al.
Translational Pediatrics|February 3, 2016
Energy metabolism in neuroblastoma and Wilms tumorSepideh Aminzadeh, Silvia Vidali, Wolfgang Sperl, et al.
Journal of Inherited Metabolic Disease|April 30, 2014
Lipoic acid biosynthesis defectsJohannes A Mayr, René G Feichtinger, Frederic Tort, et al.
Antioxidants (Basel, Switzerland)|August 26, 2023
Role of Hydrogen Sulfide in Inflammatory Bowel DiseaseNathalie Stummer, René G Feichtinger, Daniel Weghuber, et al.
Genes|June 28, 2023
Case Report-An Inherited Loss-of-Function <i>NRXN3</i> Variant Potentially Causes a Neurodevelopmental Disorder with Autism Consistent with Previously Described 14q24.3-31.1 DeletionsRené G Feichtinger, Martin Preisel, Karin Brugger, et al.
Oncotarget|July 27, 2011
No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesisKatharina Bluemlein, Nana-Maria Grüning, René G Feichtinger, et al.
Oxidative Medicine and Cellular Longevity|December 13, 2018
Reduced Levels of ATP Synthase Subunit ATP5F1A Correlate with Earlier-Onset Prostate CancerRené G Feichtinger, Georg Schäfer, Christof Seifarth, et al.
Seminars in Cell & Developmental Biology|May 31, 2019
From old to new - Repurposing drugs to target mitochondrial energy metabolism in cancerSepideh Aminzadeh-Gohari, Daniela D Weber, Silvia Vidali, et al.
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Journal of Oncology|November 30, 2019
Targeting L-Lactate Metabolism to Overcome Resistance to Immune Therapy of Melanoma and Other Tumor EntitiesRené G Feichtinger, Roland Lang
Experimental Dermatology|July 2, 2014
Mitochondrial dysfunction: a neglected component of skin diseasesRené G Feichtinger, Wolfgang Sperl, Johann W Bauer, et al.
Journal of Mother and Child|November 12, 2020
The switch in the diagnosis of mitochondrial diseases from the classical 'function first' to the NGS-based 'genetics first' diagnostic eraWolfgang Sperl, Saskia Wortmann, René G Feichtinger, et al.
Translational Pediatrics|February 3, 2016
Energy metabolism in neuroblastoma and Wilms tumorSepideh Aminzadeh, Silvia Vidali, Wolfgang Sperl, et al.
Journal of Inherited Metabolic Disease|April 30, 2014
Lipoic acid biosynthesis defectsJohannes A Mayr, René G Feichtinger, Frederic Tort, et al.
Antioxidants (Basel, Switzerland)|August 26, 2023
Role of Hydrogen Sulfide in Inflammatory Bowel DiseaseNathalie Stummer, René G Feichtinger, Daniel Weghuber, et al.
Genes|June 28, 2023
Case Report-An Inherited Loss-of-Function <i>NRXN3</i> Variant Potentially Causes a Neurodevelopmental Disorder with Autism Consistent with Previously Described 14q24.3-31.1 DeletionsRené G Feichtinger, Martin Preisel, Karin Brugger, et al.
Oncotarget|July 27, 2011
No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesisKatharina Bluemlein, Nana-Maria Grüning, René G Feichtinger, et al.
Oxidative Medicine and Cellular Longevity|December 13, 2018
Reduced Levels of ATP Synthase Subunit ATP5F1A Correlate with Earlier-Onset Prostate CancerRené G Feichtinger, Georg Schäfer, Christof Seifarth, et al.
Seminars in Cell & Developmental Biology|May 31, 2019
From old to new - Repurposing drugs to target mitochondrial energy metabolism in cancerSepideh Aminzadeh-Gohari, Daniela D Weber, Silvia Vidali, et al.
Pageof 10